# Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

> **NCT03469531** · PHASE2 · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Neoplasms
- Cervical Adenosquamous Cell Carcinoma
- Cervical Squamous Cell Carcinoma in Situ
- Stage IB Cervical Cancer
- Stage IIA Cervical Cancer
- Stage IIB Cervical Cancer
- Stage III Cervical Cancer
- Stage IVA Cervical Cancer

## Interventions

- **DRUG:** Nimotuzumab
- **DRUG:** Cisplatin
- **RADIATION:** external-beam radiation
- **RADIATION:** brachytherapy

## Key facts

- **NCT ID:** NCT03469531
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-20
- **Primary completion:** 2021-03-10
- **Final completion:** 2021-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03469531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03469531, "Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03469531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*